US Company Pfizer has withdrawn its application for the permission of the Corona vaccine in India. But experts from the Government of India say that the company has not withdrawn the application, rather its proposal has been rejected.
In a meeting held on February 3, experts had sought safety information from representatives of the company, but Pfizer could not show a single document based on which it was said that the corona vaccine was completely safe for the Indian people.
Experts have said that half the incomplete documents were submitted by Pfizer Company on the basis of which they were seeking permission for emergency use in India. But when experts reviewed their post-marketing situation and the events unfolding after vaccination, it was revealed that Pfizer was not in a position to develop vaccine safety and adequate antibodies based on mRNA technology.
During this time, the experts asked what is the effect of the vaccine on the Indian people? It is important to know the study, but the company has no answer because the Pfizer vaccine has not been tested in India. Therefore, after lengthy discussion and debate, experts have recommended not allowing Pfizer to the Drug Controller General of India.
However, Pfizer will remain in touch with the authority and re-apply for permission with additional information to ensure vaccine availability in the near future. It is necessary to have a temperature of 70 degrees to keep Pfizer’s vaccine safe. It is necessary to take two doses, which is about Rs 2862. Therefore, this vaccine is also quite different from both vaccines in India.
